Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.8 HKD | -1.03% | +2.35% | +6.90% |
Apr. 22 | Genertec Universal Medical Group Company Limited Announces Change of Address of Head Office | CI |
Apr. 17 | Genertec Universal Medical Unit to Raise Up to 2 Billion Yuan from Bond Issue | MT |
Strengths
- The company returns high margins, thereby supporting business profitability.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Corporate Financial Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.90% | 1.16B | - | ||
+58.03% | 24.6B | - | - | |
+57.76% | 7.85B | D | ||
+4.69% | 5.55B | C | ||
+2.52% | 5.01B | C+ | ||
+6.45% | 4.55B | C+ | ||
+48.92% | 3.35B | - | C+ | |
+11.92% | 2.69B | - | ||
+16.22% | 1.79B | - | C- | |
-4.73% | 1.11B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 2666 Stock
- Ratings Genertec Universal Medical Group Company Limited